Integrin activator checkpoint inhibitor compositions
US10709781B2 · kind B2 · utility
1Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2019 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Jul 19, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/732
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for priming of vaccines including administering to a patient a composition including one or more integrin activating compounds capable of adjuvanting an antigen and capable of adjuvanting one or more antigens contained in a vaccine preparation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.